Greece Approves Colchicine for Patients With COVID-19 based on Results of COLCORONA Trial
On Sunday January 24th, Greece approved colchicine, an inexpensive medicine for gout, among other things, to be included in the […]
Montreal Heart Institute’s COLCORONA Trial Reveals Colchicine Treats Reduces Hospitalization & Death Rates Associated with COVID-19
TrialSite News has followed the COLCORONA trial with interest, reporting recently that the findings were looking promising. Now the sponsor, […]
University of Oxford RECOVERY Trial Targeting Hospitalized COVID-19 Patients Now Includes Economical and Widely Available Colchicine
TrialSite recently reported that the independent data monitoring committee recommended to continue the Montreal Heart Institute study investigating the use of […]
Independent Data Monitoring Committee Recommends Continuing COLCORONA Study Indicating Potential of Colchicine
Back in June, TrialSite introduced the COLCORONA study led by the Montreal Heart Institute—a Phase 3 randomized, double-blind, placebo-controlled multicenter trial […]
UT Southwestern Testing Favipiravir, Colchicine & Monoclonal Antibodies to Find Treatments for Mild to Moderate COVID-19 Cases
UT Southwestern Medical Center researchers are investigating existing, available drugs that could potentially help treat mild to moderate COVID-19 cases. […]
At-Home Decentralized COLCORONA Trial Investigates if Colchicine Keeps COVID-19 Symptoms from Progressing to Reduce Hospitalization & Death
There is presently no available, FDA-approved medicine that can be administered at a patient’s home that can prevent the negative […]
Montreal Heart Institute Investigates if Gout Medicine Can Reduce Rate of Death & Lung Complications Associated with COVID-19
The Montreal Heart Institute recently announced that the independent data monitoring committee (DMC) of a clinical trial, after completing a […]
COLCHICINE-PCI Trial Reveals no Benefit of Colchicine Given Orally Prior to PCI
A clinical investigator from the VA New York Harbor Healthcare System in New York, NY, recently presented results of the […]
